CyclosporineÀ¸·Î Ä¡·áÇÑ Æ÷Áø»ó ³ó°¡Áø 1¿¹
A Case of Impetigo Herpetiformis Treated with Cyclosporine
Á¶Àºº°, ¹ÚÀºÁÖ, Á¶ÈñÁø, ±è±¤È£, ±è±¤Áß, ½Â³ª¸£, ÃÖ¿ìÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶Àºº° ( Cho Eun-Byul )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
¹ÚÀºÁÖ ( Park Eun-Ju )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
Á¶ÈñÁø ( Jo Hee-Jin )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
±è±¤È£ ( Kim Kwang-Ho )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
±è±¤Áß ( Kim Kwang-Joong )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
½Â³ª¸£ ( Seung Na-Reu )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
ÃÖ¿ìÁø ( Choi Woo-Jin )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
KMID : 0363220100480050420
Abstract
Impetigo herpetiformis is a rare, severe dermatologic disorder that is similar to a type of pustular psoriasis that predominantly occurs during the 3rd trimester of pregnancy. This condition usually resolves after delivery and it rarely continues until the postpartum period. Systemic corticosteroids have proven to be the drug of choice for the management of impetigo herpetiformis. In the postpartum period, oral retinoids such as isotretinoin, etretinate and acitretin can be used to control impetigo herpetiformis, but their side effect such as teratogenicity is a big issue to women of child-bearing age. We report here on a case of impetigo herpetiformis in a 28-year-old woman who did not respond to oral corticosteroids, but she was treated successfully with cyclosporine. To the best of our knowledge this is the first case of impetigo herpetiformis treated with cyclosporine in the Korean medical literature.
Å°¿öµå
Cyclosporine;Impetigo herpetiformis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸